Nuclear Targeting of Protein Phosphatase-1 by HIV-1 Tat Protein-Reference-Cited by-同舟云学术

Nuclear Targeting of Protein Phosphatase-1 by HIV-1 Tat Protein

Published:2005-10 Issue:43 Volume:280 Page:36364-36371
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ammosova Tatyana,Jerebtsova Marina,Beullens Monique,Lesage Bart,Jackson Angela,Kashanchi Fatah,Southerland William,Gordeuk Victor R.,Bollen Mathieu,Nekhai Sergei

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference43 articles.

1. Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy

2. Phosphorylation of the RNA Polymerase II Carboxyl-Terminal Domain by CDK9 Is Directly Responsible for Human Immunodeficiency Virus Type 1 Tat-Activated Transcriptional Elongation

3. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro

4. HIV-1 Tat Stimulates Transcription Complex Assembly through Recruitment of TBP in the Absence of TAFs

5. Effects of integration and replication on transcription of the HIV-1 long terminal repeat.

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The NS2B-PP1α-eIF2α axis: Inhibiting stress granule formation and Boosting Zika virus replication;PLOS Pathogens;2024-06-27

2. Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections;Cell Communication and Signaling;2024-01-24

3. Ebola Virus NP Binding to Host Protein Phosphatase-1 Regulates Capsid Formation;2023-06-06

4. HIV-1 Transcription Inhibitor 1E7-03 Decreases Nucleophosmin Phosphorylation;Molecular & Cellular Proteomics;2023-02

5. Patent Highlights June–July 2022;Pharmaceutical Patent Analyst;2023-01